Thrombosis Research
Volume 120, Supplement 1 , Pages S3-S4, 2007

Erik von Willebrand

Centre for Thrombosis and Haemostasis, Malmö University Hospital, Malmö, Sweden

Abstract 

In 1926, Erik von Willebrand, a Finnish physician, published the first manuscript describing a haemorrhagic disorder in people who were living on the Åland islands off the coast of Finland. This disorder is now known by the name of its discoverer. Since this early observation, von Willebrand disease has been extensively studied. Today, we know the structure and function of the von Willebrand factor and much of its molecular biology. With the availability of safe and effective products, the treatment of von Willebrand disease is continually improving.

Keywords: von Willebrand disease, VWD, von Willebrand factor, VWF, History of VWD, Inherited bleeding disorder

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0049-3848(07)00113-2

doi:10.1016/j.thromres.2007.03.010

Thrombosis Research
Volume 120, Supplement 1 , Pages S3-S4, 2007